Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to BIOSIMILARS

Specialty Pharmacy Continuum

Change to FDA Biosimilar Labeling Guidelines to Have Little Effect on Consumers

Clinical Pharmacology October 30th 2023

Practical Neurology

First Biosimilar to Treat Relapsing Multiple Sclerosis Approved by FDA

Neurology September 6th 2023

Clinical Oncology News

340B Participation May Hamper Biosimilars Uptake

Clinical Pharmacology September 5th 2023

Oncology News Central (ONC)

ADC Therapeutics Pauses Enrollment in Cancer Drug Trial After Patient Deaths

Hematology/Oncology July 18th 2023

Journal of the American Pharmacists Association (JAPhA)

Pharmacist Biosimilar Survey Reveals Knowledge Gaps

Clinical Pharmacology April 27th 2023

Specialty Pharmacy Continuum

Bright Future for Biosimilars

All Specialties October 27th 2022

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form